TY  - JOUR
AU  - Bailen, Rebeca
AU  - Pascual-Cascon, Maria Jesus
AU  - Guerreiro, Manuel
AU  - Lopez-Corral, Lucia
AU  - Chinea, Anabelle
AU  - Bermudez, Arancha
AU  - Sampol, Antonia
AU  - Heras, Inmaculada
AU  - Garcia-Torres, Estefania
AU  - Torres, Melissa
AU  - Roca, Jose Rifon
AU  - Herruzo, Beatriz
AU  - Sanz, Jaime
AU  - Fonseca, Marta
AU  - Herrera, Pilar
AU  - Colorado, Mercedes
AU  - Bento, Leyre
AU  - Lopez-Godino, Oriana
AU  - Martin-Calvo, Carmen
AU  - Fernandez-Caldas, Paula
AU  - Marcos-Jubilar, Maria
AU  - Sanchez-Ortega, Isabel
AU  - Solano, Carlos
AU  - Noriega, Victor
AU  - Humala, Karem
AU  - Oarbeascoa, Gillen
AU  - Diez-Martin, Jose Luis
AU  - Kwon, Mi
PY  - 2022
DO  - 10.1016/j.jtct.2022.01.020
UR  - http://hdl.handle.net/10668/22338
T2  - Transplantation and cellular therapy
AB  - Post-transplantation cyclophosphamide (PTCY) effectively prevents graft-versus-host disease (GVHD) after unmanipulated HLA-haploidentical hematopoietic stem cell transplantation (HSCT) and achieves low rates of GVHD in HLA-identical transplantation....
LA  - en
PB  - Elsevier
KW  - Acute myeloid leukemia
KW  - GVHD prophylaxis
KW  - Post-transplantation cyclophosphamide
KW  - Cyclophosphamide
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Retrospective Studies
KW  - Transplantation Conditioning
KW  - Unrelated Donors
TI  - Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
TY  - research article
VL  - 28
ER  -